期刊文献+
共找到84篇文章
< 1 2 5 >
每页显示 20 50 100
米药析要 被引量:3
1
作者 姚杰良 吴素蓉 黎忠民 《中医药导报》 2008年第12期79-81,共3页
对以米命名的果实类药物,如薏米、粳米、糯米等13种米药的来源、性味、成份、功效、运用进行介绍,展示了米药的临床实用价值。
关键词 米药 临床运用
下载PDF
广东乃至全国盐米药醋抢购背后的心理分析 被引量:1
2
作者 徐艳平 《社会心理科学》 2003年第2期15-16,23,共3页
2003年2月10日到13日,在广东的各个市县出现了群众抢购盐米的风波,在此之前已出现了抢购药品和白醋的事件,如此规模的抢购事件绝对不是偶然的,本文将从根本上对这种现象做以剖析。这样不仅会对人们产生教育作用,而且还会对今后的谣言起... 2003年2月10日到13日,在广东的各个市县出现了群众抢购盐米的风波,在此之前已出现了抢购药品和白醋的事件,如此规模的抢购事件绝对不是偶然的,本文将从根本上对这种现象做以剖析。这样不仅会对人们产生教育作用,而且还会对今后的谣言起到预防的作用,保证社会和物价的平稳。 展开更多
关键词 广东 中国 米药醋抢购事件 从众效应 心理分析 物价 社会稳定
下载PDF
耐高温米酒曲药的研制 被引量:3
3
作者 刘念 胡承 +1 位作者 彭奎 常少健 《酿酒科技》 北大核心 2008年第4期62-64,共3页
以优质大曲、小曲及酒糟为原料,筛选出耐高温根霉菌、耐高温耐酒精酵母菌和产酯酵母。利用筛选出的菌株制得耐高温米酒曲药,通过正交实验确定出曲药的最佳配方,将该曲药应用于米酒生产中,经分析,其发酵酒精度达13.5%vol,产酯能力达0.347... 以优质大曲、小曲及酒糟为原料,筛选出耐高温根霉菌、耐高温耐酒精酵母菌和产酯酵母。利用筛选出的菌株制得耐高温米酒曲药,通过正交实验确定出曲药的最佳配方,将该曲药应用于米酒生产中,经分析,其发酵酒精度达13.5%vol,产酯能力达0.347g/L,产酸能力达0.183g/L。 展开更多
关键词 酒曲 根霉 酵母 耐高温酒曲
下载PDF
多发性骨髓瘤细胞对硼替佐米耐药机制的研究进展 被引量:19
4
作者 施玲玲 翟勇平 《中国实验血液学杂志》 CAS CSCD 北大核心 2017年第5期1576-1579,共4页
近十年来,硼替佐米(bortezomib,BTZ)在血液恶性肿瘤尤其是多发性骨髓瘤(multiple myeloma,MM)和套细胞淋巴瘤(mantle cell lymphoma,MCL)的治疗中起到了非常重要的作用,尽管如此,继发性耐药的出现为该药物的临床使用带来了很大的挑战。... 近十年来,硼替佐米(bortezomib,BTZ)在血液恶性肿瘤尤其是多发性骨髓瘤(multiple myeloma,MM)和套细胞淋巴瘤(mantle cell lymphoma,MCL)的治疗中起到了非常重要的作用,尽管如此,继发性耐药的出现为该药物的临床使用带来了很大的挑战。本文根据近年来对硼替佐米耐药机制的研究现状,从泛素蛋白酶体系统(ubiquitin-proteasome system,UPS)的作用、内质网应激通路、自噬作用、细胞促存活信号通路和骨髓微环境等方面作一综述,并探讨耐药机制中可能存在的新的治疗策略。近年来随着对耐药机制的不断研究,新的组蛋白去乙酰化酶抑制剂(histone deacetylase inhibitors,HDACi)已经被用于MM的治疗,AKT抑制剂也处于临床试验阶段,这些新的联合治疗方法有望增强硼替佐米的疗效,改善患者的预后。 展开更多
关键词 多发性骨髓瘤 硼替佐 泛素蛋白酶体系统 自噬
下载PDF
浓缩型天然营养黑米的营养与效果 被引量:1
5
作者 赵则胜 《作物研究》 2004年第4期219-221,共3页
上海交通大学农业与生物学院天然健康食品研究所,培育了乌贡药稻并用它作为原料,通过高新技术物理提取法,浓缩了乌贡稻米中对人体健康的有效成分,研制成天然营养922黑米素和04型黑米素,该科研产品中富含B族维生素,维生素E,矿质元素铁、... 上海交通大学农业与生物学院天然健康食品研究所,培育了乌贡药稻并用它作为原料,通过高新技术物理提取法,浓缩了乌贡稻米中对人体健康的有效成分,研制成天然营养922黑米素和04型黑米素,该科研产品中富含B族维生素,维生素E,矿质元素铁、锌、钙、镁、钾及粗纤维和黄酮,花青素等生理活性物质,尤其是自然紫红色素的含量极其丰富,为此黑米素是新一代高营养健康品又是新型天然营养色素。 展开更多
关键词 黑稻 乌贡 营养 效果
下载PDF
铁代谢在多发性骨髓瘤疾病进程和耐药中的研究进展 被引量:1
6
作者 李艳英 张柳芸 +1 位作者 向云会 张娟 《中国实验血液学杂志》 CAS CSCD 北大核心 2023年第6期1916-1920,共5页
铁代谢参与了包括多发性骨髓瘤(MM)在内的多种恶性肿瘤的发生发展及耐药过程。本文根据近年来铁代谢与MM的相关研究,从铁过载导致MM细胞铁死亡、缺铁在MM细胞氧化呼吸与增殖中的作用、铁死亡与自噬的相互影响在疾病进程中的作用等方面... 铁代谢参与了包括多发性骨髓瘤(MM)在内的多种恶性肿瘤的发生发展及耐药过程。本文根据近年来铁代谢与MM的相关研究,从铁过载导致MM细胞铁死亡、缺铁在MM细胞氧化呼吸与增殖中的作用、铁死亡与自噬的相互影响在疾病进程中的作用等方面综述了铁代谢与MM疾病进程的关系,并简述了铁代谢相关物质通过诱导氧化还原失衡、巨噬细胞M2极化导致MM细胞对蛋白酶体抑制剂耐药的机制,旨在为调节铁代谢相关药物应用于MM患者的临床治疗提供理论基础。 展开更多
关键词 多发性骨髓瘤 铁代谢 铁死亡 硼替佐
下载PDF
乳酸脱氢酶A乙酰化修饰促进多发性骨髓瘤对硼替佐米耐药的初步机制探索
7
作者 黄蓓晖 李娟 +4 位作者 谷景立 邝丽芬 陈美兰 刘俊茹 李晓哲 《临床血液学杂志》 CAS 2024年第1期34-40,共7页
目的:探讨乳酸脱氢酶A(lactate dehydrogenase A,LDHA)乙酰化调节促进多发性骨髓瘤(multiple myeloma,MM)对硼替佐米(bortezomib,BTZ)耐药的可能机制。方法:在骨髓瘤患者中检测LDHA表达与BTZ敏感性的关系。构建对BTZ耐药的骨髓瘤细胞株... 目的:探讨乳酸脱氢酶A(lactate dehydrogenase A,LDHA)乙酰化调节促进多发性骨髓瘤(multiple myeloma,MM)对硼替佐米(bortezomib,BTZ)耐药的可能机制。方法:在骨髓瘤患者中检测LDHA表达与BTZ敏感性的关系。构建对BTZ耐药的骨髓瘤细胞株,检测耐药株与敏感株LDHA的表达情况。用CCK8检测BTZ处理后骨髓瘤耐药和敏感株的细胞增殖,用流式细胞仪检测BTZ处理后耐药和敏感株的凋亡率。在iHypoxia数据库中对LDHA可能的翻译后修饰位点进行预测,并对常见的翻译后修饰进行检测。为了探索LDHA上游调控机制,使用不同的抑制剂处理骨髓瘤细胞后检测LDHA的表达情况。结果:MM患者肿瘤组织的LDHA表达明显高于对照组,且对BTZ耐药患者LDHA的蛋白和mRNA表达明显高于对BTZ敏感的患者。成功构建BTZ诱导耐药的MM1.s-_(BR)和NCI-H929-_(BR)耐药细胞株。CCK8检测细胞活性证明BTZ耐药细胞株在BTZ处理后存活率高于敏感细胞株,而流式细胞仪结果显示BTZ敏感细胞株在BTZ处理后凋亡率高于耐药细胞株,以上结果证实BTZ耐药细胞株的构建成功。Western blot结果显示LDHA在BTZ耐药细胞株中的表达高于野生型细胞株。通过数据库预测,LDHA常见的翻译后修饰位点为磷酸化、乙酰化和泛素化。BTZ耐药细胞株中乙酰化水平较敏感株明显下降,而其他翻译后修饰程度耐药株和敏感株无明显差异。组蛋白脱乙酰酶类Ⅰ和Ⅱ的共同抑制剂trichostatin处理BTZ耐药细胞株后LDHA蛋白含量下降,乙酰化水平上调,且可以克服耐药株MM1.s-_(BR)对BTZ的耐药,但不能克服高表达LDHA的MM1.sLDH high对BTZ的耐药。结论:组蛋白脱乙酰酶类Ⅰ/Ⅱ可能通过促进LDHA的去乙酰化提高LDHA水平,促进MM对BTZ耐药。 展开更多
关键词 多发性骨髓瘤 乳酸脱氢酶A 硼替佐 乙酰化
原文传递
Determination of Zolmitriptan in Human Plasma by High-Performance Liquid Chromatography-Electrospray Mass Spectrometry and Study on Its Pharmacokinetics 被引量:2
8
作者 姚金成 瞿延晖 +4 位作者 赵绪元 胡领 朱荣华 李焕德 丁劲松 《Journal of Chinese Pharmaceutical Sciences》 CAS 2005年第1期25-28,共4页
Aim To establish a new and sensitive HPLC-MS method for the determination ofzolmitriptan in human plasma and study the pharmacokinetics of zolmitriptan in healthy volunteers.Methods A single oral dose of 5 mg of zolmi... Aim To establish a new and sensitive HPLC-MS method for the determination ofzolmitriptan in human plasma and study the pharmacokinetics of zolmitriptan in healthy volunteers.Methods A single oral dose of 5 mg of zolmitriptan tablet was given to 20 healthy male volunteers.After dosing, blood samples were collected for a period of 24 h, and zolmitriptan concentration inplasma was analyzed by HPLC-MS. Results The plasma concentration-time course fitted well atwo-compartment open model with a lag time, giving the following pharmacokinetic parameters: T_(max)1.60 ± 0.24 h, C_(max) 9.73 ± 1.43 ng·mL^(-1). T_(1/2α)1.72±0.46 h, T_(1/2β) 4.52 + 0.97 h,and AUC_(0-t) 55.59 ± 5.12 ng·mL^(-1)·h. Conclusion The improved analytical method forzolmitriptan is rapid, sensitive and suitable for application to pharmacokinetic studies and routinedetermination of numerous samples. 展开更多
关键词 ZOLMITRIPTAN PHARMACOKINETICS HPLC-MS
下载PDF
Preparation of Cetyl-Chitosan Nanoparticles as Carriers for Paracetamol 被引量:1
9
作者 代昭 孙多先 郭瑶 《Transactions of Tianjin University》 EI CAS 2002年第4期235-238,共4页
Cetyl-chitosan, prepared by reacting chitosan with chlorocetane under alkaline condition, is soluble and spontaneously forms nanoparticles about 100 nm in diameter. Infrared spectra (IR) revealed that there was a subs... Cetyl-chitosan, prepared by reacting chitosan with chlorocetane under alkaline condition, is soluble and spontaneously forms nanoparticles about 100 nm in diameter. Infrared spectra (IR) revealed that there was a substitution reaction mainly on the amine groups of chitosan (CS). By using paracetamol (PCTM) as a model drug, the balanced release concentration of PCTM in phosphate buffer solution (pH=7.4) can be decreased with the increase of degree of substitution alkyl and can be reduced effectively even under a lower PCTM loading. 展开更多
关键词 CHITOSAN cetyl-chitosan NANOPARTICLES drug delivery system PARACETAMOL
下载PDF
Release Model of Water-soluble Chitosan Nanoparticles for Protein Delivery 被引量:2
10
作者 王春 孙胜玲 +2 位作者 肖惠宁 何北海 杨连生 《Agricultural Science & Technology》 CAS 2009年第3期144-147,共4页
[Objective] The experiment aimed to explore release rule of water-soluble chitosan (WSC) in vitro. [Method]The bovine serum albumin(BSA) was taken as a model protein drug and some existing release models such as Kinet... [Objective] The experiment aimed to explore release rule of water-soluble chitosan (WSC) in vitro. [Method]The bovine serum albumin(BSA) was taken as a model protein drug and some existing release models such as Kinetics model, Gompertz model, Weibull model, Higuchi model and Logistic model were used to fit the BSA release profile from WSC carriers. [Result] Except Higuchi model and Logistic model, other models could fit BSA release profile better. [Conclusion] Gompertz two-order kinetics model could fit the release of WSC nano-particles better and model parameters had practical physical meaning. 展开更多
关键词 Water-soluble chitosan Nano-particle carriers Protein delivery Release model
下载PDF
Alginate-Coated Fe3O4 Hollow Microspheres for Drug Delivery
11
作者 董丽娟 金谷 《Chinese Journal of Chemical Physics》 SCIE CAS CSCD 2015年第2期193-196,I0002,共5页
Novel hollow Fe3O4 nanoparticles for drug delivery were synthesized via a one-step template- free approach. These nanoparticles were obtained by modifing the Fe3O4 nanoparticles with 3-aminopropyltrimethoxy silane, an... Novel hollow Fe3O4 nanoparticles for drug delivery were synthesized via a one-step template- free approach. These nanoparticles were obtained by modifing the Fe3O4 nanoparticles with 3-aminopropyltrimethoxy silane, and then grafting alginate onto the surface of amine magnetic. The hollow structure of Fe3O4 spheres was characterized by TEM, XRD, and XPS. The M-H hysteresis loop indicated that the magnetic spheres exhibit snperparamagnetic characteristics at room temperature. Daunorubicin acting as a model drug was loaded into the carrier, and the maximum percent of envelop and load were 28.4% and 14.2% respectively. The drug controlled releasing behaviors of the carriers were compared in different pH media. 展开更多
关键词 Hollow Fe3O4 nanoparticles 3-Aminopropyltrimethoxy silane Drug delivery
下载PDF
Comparative Physical Localization of Rice Pib Gene and Its Linked RFLP Markers in Oryza sativa, O. officinalis and Zea mays 被引量:3
12
作者 李霞 宁顺斌 +1 位作者 金危危 宋运淳 《Acta Botanica Sinica》 CSCD 2002年第1期49-54,共6页
Comparative genetic studies have shown that there are widespread synteny and colinearity of the genes among different species within grass family. Rice ( Oryza sativa L.) is a model plant, and analysis of its genome a... Comparative genetic studies have shown that there are widespread synteny and colinearity of the genes among different species within grass family. Rice ( Oryza sativa L.) is a model plant, and analysis of its genome allows us to reveal the common features and the evolutionary rules of the gramineous genomes and accumulate the data for establishment of a common genetic system in the Poaceae. In this study, a rice gene Pib ( 10.3 kb), a map-based cloned gene, and RFLP markers linked with it are used as the tested probes to investigate their homology and physical location among the tested species. Southern blotting analysis showed that there were sequences homologous to Pib in maize genome. Further, Pib was localized onto the chromosomes of O. sativa ssp. indica cv. Guangluai 4, O. officinalis Wall ex Watt and the inbred line of Zea mays cv. Huangzao 4. The results of fluorescence in situ hybridization (FISH) and double-color FISH indicated that a synteny of Pib and RFLP markers linked with Pib existed among the genomes of the three tested species. 展开更多
关键词 RICE RFLP markers double-color FISH PIB comparative physical mapping
下载PDF
Observation on Apoptosis of Erythroid Cells Induced by Dexamethasone
13
作者 张世馥 沈江波 章静波 《Developmental and Reproductive Biology》 1997年第2期47-52,共6页
Using splenic cells of BALB/c mice infected with Friend Leukemia Virus (FVA) as a model of erythroid cells, we investigated the action of dexamethasone (Dex) to induce apoptosis of the cells in the presence of erythro... Using splenic cells of BALB/c mice infected with Friend Leukemia Virus (FVA) as a model of erythroid cells, we investigated the action of dexamethasone (Dex) to induce apoptosis of the cells in the presence of erythropoietin (EPO)——an apoptotic inhibitor in developing erythroid cells. The result indicated that after treatment with a certain range of Dex concentrations and prolonged incubation, the cells were characterized by the occurrence of DNA ladders which appeared on agarose electrophoresis. Transmission electron microscopy showed that karyopyknosis, chromatin condensation, dilatation of the perinuclear space, karyorrhexis, cytoplasmic vacuolization and cell fragmentation appeared in the cells depending on the dose of Dex and the treatment time. These results suggest that Dex could induce apoptosis in the developing erythroid cells as in other cells so far reported. 展开更多
关键词 APOPTOSIS DEXAMETHASONE erythroid cell ERYTHROPOIETIN transmission electron microscopy
下载PDF
自噬抑制剂ROC-325抗多发性骨髓瘤作用的研究 被引量:2
14
作者 石檬涯 姚瑶 +3 位作者 邓飓 袁灿丽 刘慧敏 李振宇 《中国实验血液学杂志》 CAS CSCD 北大核心 2021年第3期797-804,共8页
目的:探讨自噬抑制剂ROC-325对人多发性骨髓瘤细胞株增殖、凋亡、自噬的影响及其与硼替佐米联合用药的细胞学效应。方法:不同浓度的ROC-325作用于骨髓瘤细胞,用CCK-8法检测药物对细胞增殖的作用,用Caspase-3/7、Caspase-9活性测定法检... 目的:探讨自噬抑制剂ROC-325对人多发性骨髓瘤细胞株增殖、凋亡、自噬的影响及其与硼替佐米联合用药的细胞学效应。方法:不同浓度的ROC-325作用于骨髓瘤细胞,用CCK-8法检测药物对细胞增殖的作用,用Caspase-3/7、Caspase-9活性测定法检测药物对细胞凋亡的影响,用单丹磺酰戊二胺染色观察自噬小体数量,Western blot检测各组细胞凋亡相关蛋白(PARP和Caspase-3)和自噬相关蛋白(P62、Beclin-1和LC3A/B)的表达情况,用CCK-8法检测ROC-325联合硼替佐米对硼替佐米耐药细胞株的抑制作用。结果:ROC-325可呈剂量依赖性抑制RPMI 8226、RPMI 8226-BTZ100、U266和IM9细胞增殖(r=-0.8275,r=-0.9079,r=-0.9422,r=-0.9305),72 h IC50分别为2.795、4.020、5.432和4.755μmol/L。Caspase-3/7、Caspase-9活性结果显示,随着药物浓度的增加,Caspase-3/7和Caspase-9相对活性逐渐升高(r=0.9648,r=0.9377,r=0.9318;r=0.9087,r=0.9431,r=0.8914)。单丹磺酰戊二胺染色结果显示,细胞内自噬泡数量随着ROC-325浓度的提高逐渐增多(r=0.9565,r=0.9373,r=0.9233)。Western blot结果显示,ROC-325可诱导凋亡相关蛋白PARP、Caspase-3表达上调以及自噬相关蛋白P62、LC3-Ⅱ/LC3-Ⅰ表达上调,Beclin-1表达下调。ROC-325联合硼替佐米的CCK-8法检测结果显示,ROC-325与硼替佐米对耐药细胞株RPMI 8226-BTZ100的抑制具有协同作用。结论:ROC-325可以抑制骨髓瘤细胞增殖,通过线粒体途径诱导骨髓瘤细胞的凋亡,通过影响自噬体和溶酶体的融合抑制骨髓瘤细胞的自噬,ROC-325联合硼替佐米后可以克服硼替佐米耐药。 展开更多
关键词 ROC-325 自噬 凋亡 多发性骨髓瘤 硼替佐
下载PDF
Preparation and Analysis of Fe3O4 Magnetic Nanoparticles Used as Targeted-drug Carriers 被引量:32
15
作者 赵原壁 邱祖民 黄佳英 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2008年第3期451-455,共5页
Fe3O4 magnetic nanoparticles were prepared by the aqueous co-precipitation of FeCl3-6H2O and FeCl2-4H2O with addition of ammonium hydroxide. The conditions for the preparation of Fe3O4 magnetic nanoparticles were opti... Fe3O4 magnetic nanoparticles were prepared by the aqueous co-precipitation of FeCl3-6H2O and FeCl2-4H2O with addition of ammonium hydroxide. The conditions for the preparation of Fe3O4 magnetic nanoparticles were optimized, and Fe3O4 magnetic nanoparticles obtained were characterized systematically by means of transmission electron microscope (TEM), dynamic laser scattering analyzer (DLS) and X-ray diffraction (XRD). The results revealed that the magnetic nanoparticles were cubic shaped and dispersive, with narrow size distribution and average diameter of 11.4 nm. It was found that the homogeneous variation of pH value in the solution via the control on the dropping rate of aqueous ammonia played a critical role in size distribution. The magnetic response of the product in the magnetic field was also analyzed and evaluated carefully. A 32.6 mT magnetic field which is produced by four ferromagnets was found to be sufficient to excite the dipole moments of 0.05 g Fe3O4 powder 2 cm far away from the ferromagnets. In conclusion, the Fe3O4 magnetic nanoparticles with excellent properties were competent for the magnetic carders of targeted-drug in future application. 展开更多
关键词 targeted--drug FE3O4 magnetic particle nanometre
下载PDF
Relationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients,under long-term treatment schedules including lamivudine 被引量:4
16
作者 Ioannis S.Elefsiniotis Antonios Moulakakis +5 位作者 Konstantinos D.Pantazis Irene Glynou Ioannis Ketikoglou Elena Vezali Helen Kada Epameinondas Tsianos 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第13期1922-1928,共7页
AIM: Predictive value of serum b2-microglobulin (b2m)levels for virological breakthrough (VB) in HBeAg-negative chronic hepatitis B (CHB) patients under long-term treatment schedules including lamivudine (LAM).METHODS... AIM: Predictive value of serum b2-microglobulin (b2m)levels for virological breakthrough (VB) in HBeAg-negative chronic hepatitis B (CHB) patients under long-term treatment schedules including lamivudine (LAM).METHODS: Serum b2m levels were calculated during treatment in 25 CHB patients under long-term LAM monotherapy (group A) and 12 patients under initial interferon plus LAM treatment followed by LAM monotherapy (group B), using the MEIA technology. We used Cox proportional hazard models in order to investigate the association between serum b2m levels and VB.RESULTS: Seven of 25 patients (28%), 9/25 (36%) and 14/25 (56%) from group A and 0/12, 2/12 (16.6%) and 3/12 (25%) from group B exhibited VB at months 12, 24 and 36 of treatment, respectively. All patients, from both groups, who did not show VB exhibited b2m elevation in mo 3. The duration of b2m elevation was significantly longer in the virological responder's subgroup from group A than the non-responder's one (7.3±2.6 vs 3.8±3.4 mo,P = 0.02). In comparison to group A patients whose b2m levels were increased at 3 mo, patients whose b2m levels were decreased had 4.6 times higher risk of experiencing VB (RR = 4.6, P = 0.024). When baseline variables were simultaneously included in the same Cox model, decreased b2m status was still associated with increased risk of VB (RR = 12.2, P = 0.03).CONCLUSION: In HBeAg-negative CHB patients under either long-term LAM monotherapy or initial combination treatment, serum b2m levels at 3 mo of treatment,compared to baseline ones, might be a predictor of risk for VB. 展开更多
关键词 Chronic hepatitis B LAMIVUDINE INTERFERON Virological breakthrough B2-microglobulin
下载PDF
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B:Results of an open,controlled trial 被引量:10
17
作者 M. Francesca Jaboli Carlo Fabbri +12 位作者 Stefania Liva Francesco Azzaroli Giovanni Nigro Silvia Giovanelli Francesco Ferrara Anna Miracolo Sabrina Marchetto Marco Montagnani Antonio Colecchia Davide Festi Letizia Bacchi Reggiani Enrico Roda Giuseppe Mazzella 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第7期1491-1495,共5页
AIM: To investigate the safety and efficacy of long-term combination therapy with alpha interferon and lamivudine in non-responsive patients with anti-HBe-positive chronic hepatitis B.METHODS: 34 patients received com... AIM: To investigate the safety and efficacy of long-term combination therapy with alpha interferon and lamivudine in non-responsive patients with anti-HBe-positive chronic hepatitis B.METHODS: 34 patients received combination treatment (1 month lamivudine, 12 month lamivudine+interferon, 6month lamivudine), 24 received lamivudine (12 months),24 received interferon (12 months). Interferon was administered at 6 MU tiw and lamivudine at 100 mg orally once daily. Patients were followed up for 6 months after treatment.RESULTS: At the end of treatment, HBV DNA negativity rates were 88 % with lamivudine+interferon, 99 % with lamivudine and 55 % with interferon, (P=0.004, combination therapy vs. interferon, and P=0.001 lamivudine vs.interferon), and serum transaminase normalization rates were 84 %, 91% and 53 % (P=0.01 combination therapy vs. interferon, and P=0.012 lamivudine vs. interferon). Six months later, HBV DNA negativity rates were 44 % with lamivudine+interferon, 33 % with lamivudine and 25 % with interferon, and serum transaminase normalization rates were 61%, 42 % and 45 %, respectively, without statistical significance. No YMDD variants were observed with lamivudine+interferon (vs. 12 % with lamivudine). The combination therapy appeared to be safe. CONCLUSION: Although viral clearance and transaminase normalization are slower with long-term lamivudine+interferon than that with lamivudine alone, the combination regimen seems to provide more lasting benefits and to protect against the appearance of YMDD variants. Studies with other regimens regarding sequence and duration are needed. 展开更多
关键词 ADULT Antiviral Agents DOSAGE Drug Therapy Combination FEMALE Hepatitis B Chronic Humans INTERFERON-ALPHA LAMIVUDINE Male Middle Aged Reverse Transcriptase Inhibitors Treatment Outcome
下载PDF
Reduction of Praziquantel Elimination by Cimetidine in Rats
18
作者 弋苹 全钰珠 《Journal of Chinese Pharmaceutical Sciences》 CAS 1993年第2期127-132,共6页
The effect of cimetidine on the elimination of praziquantel(PQT)in rats was studied. The results showed that cimetidine 100 mg/kg,ip 2 reduced the clearances of intravenous and oral PQT by 60 and 69 percent respective... The effect of cimetidine on the elimination of praziquantel(PQT)in rats was studied. The results showed that cimetidine 100 mg/kg,ip 2 reduced the clearances of intravenous and oral PQT by 60 and 69 percent respectively.Cimetidine also markedly reduced liver blood flow of rats(a reduction of 58%)and inhibited PQT metabolism in hepatic microsomes of rats(an inhibition of 55%). The reduction in clearance of intravenous PQT could be attributed to the result of cimetidine lowering liver blood flow,whereas the reduction in clearance of oral PQT might be related mainly to the inhibition of cimetidine on the activity of hepatic drug-metabolizing enzymes. 展开更多
关键词 PRAZIQUANTEL CIMETIDINE Drug interaction Drug metabolism
下载PDF
Protective Effect of Rhubarb on Endotoxin-Induced Acute Lung Injury 被引量:1
19
作者 李春盛 周景 +2 位作者 桂培春 何新华 毛树章 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2001年第1期54-58,共5页
To approach the mechanism of lipopolysaccharide (LPS) in causing acute lung injury (ALI) and the protective effect of rhubarb and dexamethasone, lung specimens were examined with macroscopy, microscopy, electron micro... To approach the mechanism of lipopolysaccharide (LPS) in causing acute lung injury (ALI) and the protective effect of rhubarb and dexamethasone, lung specimens were examined with macroscopy, microscopy, electron microscopy and the biological markers of ALI including lung wet/dry weight, the rate of neutrophils and protein content in the pulmonary alveolar lavage fluid, pulmonary capillary permeability and pulmonary alveolar permeability index were observed. The mechanism of the ALI is mainly due to direct injury of alveolar epithelium and pulmonary vascular endothelium. Rhubarb and dexamethasone could significantly reduce the edema of the lung tissue, decrease the red blood cell exudation, neutrophil infiltration and plasma protein exudation in the alveoli and all the biological markers in comparison with the ALI model rats, indicating they have protective action on vascular endothelium and alveolar epithelium. 展开更多
关键词 PHYTOTHERAPY Plants Medicinal Animals Dexamethasone Drugs Chinese Herbal LIPOPOLYSACCHARIDES Lung Male RATS Rats Wistar Respiratory Distress Syndrome Adult RHEUM
下载PDF
Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus:A case report 被引量:4
20
作者 Yuka Suzuki Hiroshi Yotsuyanagi +7 位作者 Chiaki Okuse Yoshihiko Nagase Hideaki Takahashi Kyoji Moriya Michihiro Suzuki Kazuhiko Koike Shiro Iino Fumio Itoh 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第6期964-969,共6页
We present a case of fetal liver failure caused by the activation of larnivudine-resistant hepatitis B virus (HBV) nine months after lamivudine treatment. A 57-year old man visited our hospital for the treatment of ... We present a case of fetal liver failure caused by the activation of larnivudine-resistant hepatitis B virus (HBV) nine months after lamivudine treatment. A 57-year old man visited our hospital for the treatment of decornpensated chronic hepatitis B. Lamivudine was started in December 2001. Subsequently, serum HBV was negative for HBV DNA with seroconversion from HBeAg to anti-HBe and improvement of liver function. However, HBV DNA and HBeAg were again detected in September 2002. He was complicated by breakthrough hepatitis and admitted to our hospital in November for severely impaired liver function. Vidarabine treatment was started and serum HBV DNA and alanine aminotransferase (ALT) decreased transiently. However, after the start of m-interferon treatment, HBV DNA level increased and liver function deteriorated. He died 1 mo after admission. An analysis of amino acid sequences in the polymerase region revealed that rtM204I/V with rtLSOI/V occurred at the time of viral breakthrough. After the start of antiviral treatment, rtL180M was detected in addition to rtM204I/V and rtLSOI/V, and became predominant in the terminal stage of the disease. HBV clone with a high replication capacity may be produced by antiviral treatment leading to the worsening of liver function. Antiviral therapy for patients with breakthrough hepatitis in advanced liver disease should be carefully performed. 展开更多
关键词 Hepatitis B virus LAMIVUDINE Polymerase Interferon Tyrosine-methionine-aspartate-aspartate
下载PDF
上一页 1 2 5 下一页 到第
使用帮助 返回顶部